Healthcare Jul 26, 2021 09:15 AM (GMT+8) · EqualOcean
Yiouda health learned on the 26th that Hangzhou Yike Medical Technology Co., Ltd. (hereinafter referred to as "Yike medical") recently announced the completion of nearly 100 million yuan of round a financing. This round of financing is led by Shanghai chuangrui, and the old shareholders continue to follow. Founded in June 2020, Yike medical is mainly committed to the development and industrialization of innovative Neurointerventional medical devices, and plans to develop more products in the direction of Pan vascular in the future. It is reported that around the products under research, it has applied for more than 30 innovation patents, of which 5 patents have been authorized. Jing Hongjuan, founder and CEO of Yike medical, said that Yike medical is focusing on the field of neural intervention at this stage, and its product line mainly covers ischemic stroke treatment, hemorrhagic stroke treatment and pathway products. After this round of financing, the funds raised will be mainly used for new product R & D, the introduction of core equipment and the absorption of high-end talents. At the same time, Yike medical said that it will speed up the progress of product clinical trial and registration application, and complete the all-round strategic layout of nerve intervention products as soon as possible.